Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

Long-term Observational Study in HIV Subjects Exposed to EGRIFTA®

ClinicalTrials.gov ID: NCT01579695

Public ClinicalTrials.gov record NCT01579695. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 11:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Observational, Multicenter, 10-year Prospective Cohort Safety Study Comparing Subjects With HIV-associated Abdominal Lipohypertrophy Exposed to EGRIFTA® (Tesamorelin for Injection) to a Similar Group of Subjects Not Exposed to EGRIFTA®

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this observational, 10-year, prospective cohort study is to assess the potential safety concerns of long-term exposure to EGRIFTA® in HIV-infected subjects with abdominal lipohypertrophy compared with a similar group of subjects not exposed to EGRIFTA®.

Study identification

NCT ID
NCT01579695
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Theratechnologies
Industry
Enrollment
391 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2013 (Actual)
Primary completion
May 2018 (Actual)
Completion
Aug 2018 (Actual)
Last update posted
Sep 11, 2018

2013 – 2018

United States locations

U.S. sites
31
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Franco Felizarta, MD Bakersfield California 93301 —
Pacific Coast Medical Group Fountain Valley California 92708 —
University of California CARE Clinic, Los Angeles Los Angeles California 90035 —
Tower Infectious Diseases Medical Associates Los Angeles California 90048 —
Oasis Clinic Los Angeles California 90095 —
VAMC, Infectious Disease Section 111W San Francisco California 94121 —
Dupont Circle Physician's Group Washington D.C. District of Columbia 20009 —
Capital Medical Associates, PC Washington D.C. District of Columbia 20036 —
Gary J. Richmond, M.D., PA Fort Lauderdale Florida 33316 —
The Kinder Medical Group-AHF Miami Florida 33133 —
Orange County Health Department Orlando Florida 32805 —
Orange County Health Department Orlando Florida 32809 —
Rowan Tree Medical, P.A. Wilton Manors Florida 33305 —
Absolute Care Medical Center Atlanta Georgia 30309 —
Northstar Medical Center Chicago Illinois 60657 —
Southern Illnois University School of Medicine Springfield Illinois 62702 —
Massachusetts General Hospital Boston Massachusetts 02114 —
The Researth Institute Springfield Massachusetts 01105 —
Be Well Medical Center, P.C Berkley Michigan 48072-3436 —
Southhampton Clinical Research, Inc. d.b.a. Central West Clinical Research St Louis Missouri 63108 —
Southampton Healthcare, Inc. St Louis Missouri 63139 —
South Jersey Unfectious Disease Somers Point New Jersey 08244 —
University at Buffalo, State University of NY, Erie County Medical Center Buffalo New York 14215 —
Ricky K. Hsu, MD, PC New York New York 10011 —
Summa Health Care System Akron Ohio 44304 —
Virginia Mason Medical Center Tulsa Oklahoma 74127 —
Reading Hospital and Medical Center West Reading Pennsylvania 19611 —
St. Hope Foundation, Inc. Bellaire Texas 77401 —
Dallas VA Medical Center Dallas Texas 75216 —
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75235 —
Virginia Mason Medical Center Seattle Washington 98112 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01579695, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 11, 2018 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01579695 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →